Related Experiment Video
Updated: Dec 31, 2025

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
STAT3 activates the anti-apoptotic form of caspase 9 in oncovirus-infected B lymphocytes
Siva Koganti1, Sandeepta Burgula1, Sumita Bhaduri-McIntosh2
1Division of Infectious Diseases, Department of Pediatrics, Stony Brook University, NY, USA.
Abstract:
The cancer-causing Epstein-Barr virus (EBV) activates the transcription factor STAT3 upon infecting B-lymphocytes. STAT3 then activates caspase 7 to degrade cellular claspin, resulting in impaired Chk1 phosphorylation. This blockade of ATR-Chk1 signaling allows EBV-transformed cells to proliferate despite DNA lesions from virus-induced replication stress. In addressing the mechanism of caspase 7 activation, we now report that in newly-infected B-cells, STAT3 transcriptionally activates the initiator caspase, caspase 9. Caspase 9 then activates caspase 7 to impair phosphorylation of Chk1 at S345. Importantly, although cleaved products of caspase 9 are detectable in infected cells, there is simultaneous increase in the alternatively-spliced dominant-negative form of caspase 9 - and - expression of dominant-negative caspase 9 is abrogated when STAT3 activation is impaired. Thus EBV, via STAT3, activates caspase 9 but also shifts the balance of transcripts towards its dominant-negative form to allow activation of caspase 7 while avoiding death of EBV-infected cells.
Insights
Epstein-Barr virus (EBV) hijacks STAT3 to activate caspase 9, which then activates caspase 7. This process impairs DNA repair, allowing EBV-infected cells to survive and proliferate.
Area of Science:
- Virology
- Molecular Biology
- Cellular Biology
Background:
- Epstein-Barr virus (EBV) is a human oncogenic virus that infects B-lymphocytes.
- EBV infection leads to the activation of the STAT3 transcription factor.
- STAT3 activation is implicated in viral-induced cell proliferation and evasion of DNA damage responses.
Purpose of the Study:
- To elucidate the precise mechanism by which EBV-infected B-cells activate caspase 7.
- To investigate the role of STAT3 and caspase 9 in EBV-mediated cellular processes.
- To understand how EBV-infected cells overcome DNA replication stress and maintain proliferation.
Main Methods:
- Analysis of caspase activation pathways in EBV-infected B-lymphocytes.
- Investigation of STAT3-mediated transcriptional regulation of caspases.
- Detection of caspase cleavage products and assessment of Chk1 phosphorylation.
- Evaluation of caspase 9 splice variants in infected cells.
Main Results:
- STAT3 transcriptionally activates caspase 9 in newly EBV-infected B-cells.
- Caspase 9 subsequently activates caspase 7, leading to impaired Chk1 phosphorylation at S345.
- EBV infection induces an increase in the dominant-negative splice variant of caspase 9.
- STAT3 inhibition abrogates the expression of dominant-negative caspase 9.
Conclusions:
- EBV utilizes STAT3 to activate caspase 9, which then activates caspase 7.
- This pathway impairs ATR-Chk1 signaling, allowing EBV-transformed cells to proliferate despite DNA damage.
- EBV balances caspase 9 activation with the expression of its dominant-negative form to promote cell survival and viral replication.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Apoptosis
The JAK-STAT Signaling Pathway

